A multicenter, randomized controlled study on the efficacy of agomelatine in ameliorating anhedonia, reduced motivation, and circadian rhythm disruptions in patients with major depressive disorder (MDD)

OBJECTIVE: To evaluate the clinical efficacy and safety of Agomelatine in improving symptoms in patients with major depressive disorder (MDD), providing more scientific evidence for the treatment of depression, and offering more effective therapeutic options for patients. METHODS: A total of 180 MDD...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Ping, Xu, Yong, Lv, Liang, Feng, Min, Fang, Yu, Huang, Wei-Quan, Cheng, Shan-Fei, Qian, Min-Cai, Yang, Shengliang, Wang, Shi-Kai, Chen, Huan-Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642047/
https://www.ncbi.nlm.nih.gov/pubmed/37957751
http://dx.doi.org/10.1186/s12991-023-00473-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642047/
https://www.ncbi.nlm.nih.gov/pubmed/37957751
http://dx.doi.org/10.1186/s12991-023-00473-y

Ejemplares similares